NC, SC, GA, VA, DC, MD, TN, WVMarket Access | Payers Markets | Alzheimer's diseaseResponsible for presenting the economic value proposition and clinical benefits of Eisai product(s) to regional health system formulary stakeholders to establish brand access and a new patient care path.Responsible for Identifying and Supporting the execution of projects that directly support the economic and quality strategy for Eisai product(s) and for Deliverying work within the Health Economics Research strategy practice.

Market Access | Patient Services | Oncology*Regional payer expert for coverage issues / opportunities and Access & Reimbursement policies across the continuum *Expert point of contact for oncology sales team members; supported 8 Districts (2 RBD, 8 ABL, 40 OSS)*Identified and triaged reimbursement challenges promptly and compliantly*Implement appropriate and compliant strategies that increase access and neutralize barriers to oncology portfolio.*Educate HCP and support teams*Maintained high level of matrix team communication*Promoted to Health System Account Executive

adv|met Endometrial Carcinoma,RAI-R Differentiated Thyroid Cancer,adv|met Breast Cancer,unresectable Hepatocellular Carcinoma*Promoted to Senior Manager, Access & Reimbursement

Chronic ITP | Severe Aplastic Anemia | Chronic and Acute Myeloid Leukemia | Advanced Systemic Mastocytosis.*Coordinated customer appointments with over 12 matrix partners *Charlotte Team Collaboration Recognition

met|adv Breast Cancer*Coordinated customer appointments with over 15 matrix partners

met NSCLC with ALK+ or BRAFv600e mutations. Tuberous Sclerosis Complex- SEGA, AML.*Coordinated customer appointments with over 50 matrix partners

Generated and maintained business with the Lilly portfolio of biologics, injectables, complex infusions and oral medications. Inpatient & outpatient targets in a complex hospital system with complex disease states.

*National Award Winner Multiple Years*Experience promoting and launching complex disease states, including orphan drug infusions, in complex hospital environments involving a total hospital and office sell.Cardiovascular - Monoclonal Antibody Glycoprotein 2b3a Receptor Inhibitor bolus and infusion for ACS-PCI (Reopro / abciximab) and P2Y12 Receptor Inhibitor (Effient / prasugrel)Diabetes - Recombinant Human Insulins, Analog and Follow-on Biologic injectables (Humalog / lispar, Humulin / human recombinant, Basaglar / glargine)Orphan Drug for Severe Sepsis -Recombinant form of Human Activated Protein C 96-hour infusion (Xigris / drotecogin alpha - activated Protein C)Neuroscience - Oral tablets and dissolvables (Prozac, Zyprexa, Prozac Weekly, Sarafem, Symbyax, Strattera, Cymbalta)

*Generated and maintained sales of injectable / complex infusion therapy for ACS-PCI in: Cardiac Cath Lab, ED, Inpatient Departments, Critical Care, Pulmonary, Infectious Disease, Pharmacy, Interventional Cardiology, Endocrinology, Trauma, Surgeons, Emergency Med. *Promoted to Executive Sales

*Successful launches of 5 neuroscience oral and dissolvable pharmaceuticals in mental health hospital units, community mental health centers and private practices.Grew territory from bottom 17% to Top 25%. *Promoted to Senior Sales*Promoted to Acute Care Division in Charlotte, NC